Hepatopulmonary syndrome natural history, complications and prognosis: Difference between revisions
No edit summary |
|||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Soroush}} | {{CMG}}; {{AE}} {{Soroush}} | ||
==Overview== | ==Overview== | ||
If left untreated, [#]% of patients with | If left untreated, [#]% of patients with hepatopulmonary syndrome may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3]. | ||
OR | OR | ||
Common complications of | Common complications of hepatopulmonary syndrome include [complication 1], [complication 2], and [complication 3]. | ||
OR | OR | ||
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with | Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with hepatopulmonary syndrome is approximately [#]%. | ||
==Natural History, Complications, and Prognosis== | ==Natural History, Complications, and Prognosis== | ||
Line 17: | Line 17: | ||
*The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___. | *The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___. | ||
*The symptoms of (disease name) typically develop ___ years after exposure to ___. | *The symptoms of (disease name) typically develop ___ years after exposure to ___. | ||
*If left untreated, [#]% of patients with | *If left untreated, [#]% of patients with hepatopulmonary syndrome may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3]. | ||
===Complications=== | ===Complications=== | ||
*Common complications of | *Common complications of hepatopulmonary syndrome include: | ||
**[Complication 1] | **[Complication 1] | ||
**[Complication 2] | **[Complication 2] | ||
Line 26: | Line 26: | ||
===Prognosis=== | ===Prognosis=== | ||
*Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with | *Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with hepatopulmonary syndrome is approximately [--]%. | ||
*Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent. | *Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent. | ||
*The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy]. | *The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy]. | ||
*[Subtype of disease/malignancy] is associated with the most favorable prognosis. | *[Subtype of disease/malignancy] is associated with the most favorable prognosis. | ||
*The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis. | *The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis. | ||
*With liver transplantation, the 5 year survival rate is 74%, which is comparable to patients who undergo liver transplants who do not suffer from hepatopulmonary syndrome. | *With liver transplantation, the 5 year survival rate is 74%, which is comparable to patients who undergo liver transplants who do not suffer from hepatopulmonary syndrome.<ref name="pmid15828054">Swanson KL, Wiesner RH, Krowka MJ (2005) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=15828054 Natural history of hepatopulmonary syndrome: Impact of liver transplantation.] ''Hepatology'' 41 (5):1122-9. [http://dx.doi.org/10.1002/hep.20658 DOI:10.1002/hep.20658] PMID: [https://pubmed.gov/15828054 15828054]</ref> | ||
==References== | ==References== |
Revision as of 16:12, 19 July 2019
Hepatopulmonary syndrome Microchapters |
Differentiating Hepatopulmonary syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Hepatopulmonary syndrome natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Hepatopulmonary syndrome natural history, complications and prognosis |
FDA on Hepatopulmonary syndrome natural history, complications and prognosis |
CDC on Hepatopulmonary syndrome natural history, complications and prognosis |
Hepatopulmonary syndrome natural history, complications and prognosis in the news |
Blogs on Hepatopulmonary syndrome natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]
Overview
If left untreated, [#]% of patients with hepatopulmonary syndrome may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
OR
Common complications of hepatopulmonary syndrome include [complication 1], [complication 2], and [complication 3].
OR
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with hepatopulmonary syndrome is approximately [#]%.
Natural History, Complications, and Prognosis
Natural History
- The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
- The symptoms of (disease name) typically develop ___ years after exposure to ___.
- If left untreated, [#]% of patients with hepatopulmonary syndrome may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
Complications
- Common complications of hepatopulmonary syndrome include:
- [Complication 1]
- [Complication 2]
- [Complication 3]
Prognosis
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with hepatopulmonary syndrome is approximately [--]%.
- Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
- The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
- [Subtype of disease/malignancy] is associated with the most favorable prognosis.
- The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
- With liver transplantation, the 5 year survival rate is 74%, which is comparable to patients who undergo liver transplants who do not suffer from hepatopulmonary syndrome.[1]
References
- ↑ Swanson KL, Wiesner RH, Krowka MJ (2005) Natural history of hepatopulmonary syndrome: Impact of liver transplantation. Hepatology 41 (5):1122-9. DOI:10.1002/hep.20658 PMID: 15828054